Amit Shah - Jul 8, 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Amit Shah
Stock symbol
OTLC
Transactions as of
Jul 8, 2021
Transactions value $
$0
Form type
4
Date filed
7/16/2021, 05:37 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Award $0 +299K +498.06% $0.00 359K Jul 8, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Stock Options Award $0 +698K $0.00 698K Jul 8, 2021 Common Stock 698K $0.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued in settlement of Restricted Stock Units granted pursuant to the Issuer's 2015 Equity Incentive Plan that vested immediately upon grant.
F2 Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on date of grant.